Oncology & Cancer

New lung immuno-oncology therapeutic strategy identified

Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated in a preclinical study a potential new therapeutic approach to treating the most common form of lung cancer.

Medications

Developing drugs to help fight Rift Valley fever virus

Research by Lawrence Livermore National Laboratory (LLNL) scientists suggests that immune responses could be bolstered by drugs to help people recover from brain infections caused by an emerging pathogen.

page 4 from 26